butyric acid and diethoxyphosphoryloxymethyl butanoate

butyric acid has been researched along with diethoxyphosphoryloxymethyl butanoate in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Berkovitch, G; Doron, D; Malik, Z; Nudelman, A; Rephaeli, A1
Cutts, SM; Kessler-Icekson, G; Nudelman, A; Phillips, DR; Rephaeli, A; Tarasenko, I; Tarasenko, N; Waks-Yona, S1
Kessler-Icekson, G; Nudelman, A; Nudelman, V; Rephaeli, A; Zahalka, MA1

Other Studies

3 other study(ies) available for butyric acid and diethoxyphosphoryloxymethyl butanoate

ArticleYear
Novel multifunctional acyloxyalkyl ester prodrugs of 5-aminolevulinic acid display improved anticancer activity independent and dependent on photoactivation.
    Journal of medicinal chemistry, 2008, Dec-11, Volume: 51, Issue:23

    Topics: Aminolevulinic Acid; Antineoplastic Agents; Apoptosis; Butyric Acid; Cell Proliferation; Drug Screening Assays, Antitumor; Heme; Histones; HL-60 Cells; Humans; Membrane Potential, Mitochondrial; Molecular Structure; Phosphorylation; Photochemistry; Porphyrins; Prodrugs; Proteasome Inhibitors; Proto-Oncogene Proteins c-myc; Reactive Oxygen Species; Stereoisomerism; Tumor Cells, Cultured

2008
Anticancer prodrugs of butyric acid and formaldehyde protect against doxorubicin-induced cardiotoxicity.
    British journal of cancer, 2007, Jun-04, Volume: 96, Issue:11

    Topics: Animals; Animals, Newborn; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Butyrates; Butyric Acid; Cells, Cultured; Cytoprotection; Doxorubicin; Drug Evaluation, Preclinical; Female; Formaldehyde; Gene Expression Regulation; Histone Deacetylases; Membrane Potential, Mitochondrial; Mice; Mice, Inbred C57BL; Models, Biological; Myocytes, Cardiac; Organophosphates; Organophosphorus Compounds; Prodrugs; Rats

2007
Cardioprotection by AN-7, a prodrug of the histone deacetylase inhibitor butyric acid: Selective activity in hypoxic cardiomyocytes and cardiofibroblasts.
    European journal of pharmacology, 2020, Sep-05, Volume: 882

    Topics: Animals; Antineoplastic Agents; Butyrates; Butyric Acid; Cardiotonic Agents; Cell Hypoxia; Cell Line; Cell Survival; Fibroblasts; Glycogen Synthase Kinase 3 beta; Histone Deacetylase Inhibitors; Hydrogen Peroxide; MAP Kinase Signaling System; Myocytes, Cardiac; Organophosphorus Compounds; Oxidative Stress; Prodrugs; Proto-Oncogene Proteins c-akt; Rats

2020